spacer
home > epc > spring 2019 > smarter supply chains
PUBLICATIONS
European Pharmaceutical Contractor

Smarter Supply Chains

The role of the supply chain in protecting patients from unsafe medical products is crucial, with the transportation and storage of pharmaceuticals having a significant impact on product integrity. However, with the growth of biopharmaceuticals, the significance of getting logistics right becomes even more important. The stricter logistical requirements and significant costs are combined with limited supply, meaning that every batch is vital. This article will consider how supply chains can work smarter to mitigate the risks that cause product failures and better protect end-patients.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
James Colson has principally worked in the European road sector, including both own accounts and third party. More recently, this has expanded to air and ocean environments too, with a focus on healthcare solutions for pharmaceutical customers. James' in-depth knowledge has led to him heading up the internal Yusen team that is focused on Brexit, and the impacts and implications for both Yusen and our customers.

Ellena Austin has carved a career in Marketing with a vast range of experience from fashion PR to corporate events and copywriting for a number of verticals including Healthcare, Consumer Electronics and White Goods. Currently working as Marketing Executive for Yusen Logistics UK, Ellena executes the UK marketing strategy in line with regional and global directives. Within her company she holds Regional Brand Ambassador and Regional Connected Ambassador roles, representing the EU region.
spacer
Ellena Austin
spacer
spacer
spacer
James Colson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement